Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial

2000244 citationsJournal Article

Authors

Zanamivir was effective in shortening the duration and severity of influenza symptoms and was well-tolerated among children 5 to 12 years of age.

Good health and well-being

Published in: The Pediatric Infectious Disease Journal

Volume 19, Issue 5, pp. 410-417

Field-Weighted Citation Impact: 16.73